Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy
There is an extensive debate on the neurological consequences of 2019 novel coronavirus disease (COVID-19) and its impact on Parkinson’s disease (PD) patients, which seems to puzzle neurologists. Links between viral infections and PD have long been suspected and studied, but the exact relationship r...
Main Authors: | Smriti Sinha, Swati Mittal, Rupali Roy |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Movement Disorder Society
2021-09-01
|
Series: | Journal of Movement Disorders |
Subjects: | |
Online Access: | http://www.e-jmd.org/upload/jmd-21046.pdf |
Similar Items
-
Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology
by: Carmela Conte, et al.
Published: (2023-05-01) -
Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease
by: Sarah Plum, et al.
Published: (2020-12-01) -
Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease
by: Gian-Carlo Eyer, et al.
Published: (2021-11-01) -
The dosage of curcumin to alleviate movement symptoms in a 6-hydroxydopamine-induced Parkinson's disease rat model
by: Xiaoyu Liu, et al.
Published: (2023-06-01) -
Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach
by: Mojtaba Jokar, et al.
Published: (2023-02-01)